ACHV Stock Analysis for Money Stockers
Introduction
We turn our attention to Achieve Life Sciences, Inc. (ACHV), situated in the Biotechnology industry within the Healthcare sector. Trading activity on 2025-05-30 00:00:00 placed the stock price at $3.58, reflecting a robust technical setup, holding above primary moving averages. Staying above these critical SMAs generally signifies positive market sentiment and upward momentum. Its market capitalization stands near $137.35 M, ACHV represents a significant player in its field.
This report offers a multi-faceted analysis of Achieve Life Sciences, Inc. (ACHV), integrating technical signals, fundamental data, and forward-looking forecasts. The aim is to provide investors with a balanced perspective on the stock’s current market standing, potential risks (see Risk Factors), and future performance outlook.
Company Description
Its business model centers around: Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bris…
Metrics Summary
The following data points provide a summary of ACHV’s current status. With a price of $3.58, the 1-year projection aims for approximately $0.00 (+0.0%). The technical picture shows a Bullish bias (Above SMA 50, Above SMA 200). The stock’s recent volatility stands at 75.7%. The following sections provide deeper analysis into the underlying technicals and fundamentals.
Detailed Forecast Table
Here’s the breakdown of the month forecast for ACHV ($0.00 to $1,799.00 overall range). The table shows projected price bands, potential ROI against the current price, and the resulting model signal per period.
Over the forecast horizon (2025-05 to 2026-05), ACHV’s price is projected by the model to fluctuate between approximately $0.00 and $1,799.00.
The projected price range remains relatively consistent (from $2.83 – $2.83 to $0.00 – $1,188.50), implying stable forecast uncertainty.
| Month (Period) | Min. Price | Avg. Price | Max. Price | Potential ROI vs Current ($3.58) | Model Signal |
|---|---|---|---|---|---|
| 2025-05 | $2.83 | $2.83 | $2.83 | ▼ -21.1% | Consider Short |
| 2025-06 | $0.00 | $0.00 | $1,217.60 | ▼ -100.0% | Consider Short |
| 2025-07 | $0.00 | $0.00 | $1,127.41 | ▼ -100.0% | Consider Short |
| 2025-08 | $0.00 | $0.00 | $1,183.28 | ▼ -100.0% | Consider Short |
| 2025-09 | $0.00 | $0.00 | $1,470.38 | ▼ -100.0% | Consider Short |
| 2025-10 | $0.00 | $0.00 | $1,527.01 | ▼ -100.0% | Consider Short |
| 2025-11 | $0.00 | $0.00 | $1,449.76 | ▼ -100.0% | Consider Short |
| 2025-12 | $0.00 | $0.00 | $1,497.92 | ▼ -100.0% | Consider Short |
| 2026-01 | $0.00 | $0.00 | $1,061.50 | ▼ -100.0% | Consider Short |
| 2026-02 | $0.00 | $0.00 | $1,362.32 | ▼ -100.0% | Consider Short |
| 2026-03 | $0.00 | $0.00 | $1,280.18 | ▼ -100.0% | Consider Short |
| 2026-04 | $0.00 | $0.00 | $1,799.00 | ▼ -100.0% | Consider Short |
| 2026-05 | $0.00 | $0.00 | $1,188.50 | ▼ -100.0% | Consider Short |
Model forecasts like these are estimates with built-in uncertainty. They depend on current data and assumptions, which can change. Actual prices are not guaranteed.
Total Valuation
Total valuation metrics offer a broader perspective beyond market capitalization. At N/A, the Enterprise Value (EV) presents a fuller picture of ACHV’s aggregate value, accounting for both equity and net debt. Relating this EV to performance, the EV/Revenue multiple stands at N/A, and the EV/EBITDA multiple is -2.90x, gauging value against sales and core operational earnings respectively. These ratios help assess the company’s valuation relative to its sales and operating earnings. Key upcoming dates include the next earnings announcement (Est: 2025-05-13) and the ex-dividend date (N/A).
| Market Cap | $137.35 M |
| Enterprise Value | $124.07 M |
| EV/EBITDA (TTM) | -2.90x |
| Next Earnings Date | 2025-05-13 |
Profitability Growth
Here we look at ACHV’s profit generation and growth trajectory. Key profitability metrics include Gross Margin (0.00%), Operating Margin (0.00%), and Net Profit Margin (0.00%). Recent expansion is reflected in Year-over-Year Revenue Growth (N/A) and Earnings Growth (N/A). Benchmarking these profit and growth figures against the past 📜 and peers 👥 is vital for interpretation. These metrics reflect financial success and expansion capacity.
| Profit Margin (TTM) | 0.00% |
| Operating Margin (TTM) | 0.00% |
| Gross Margin (TTM) | 0.00% |
| EBITDA Margin (TTM) | 0.00% |
| EBITDA (TTM) | $-45.75 M |
| Net Income (TTM) | $-46.16 M |
Analyst Insights
Here’s the consensus from Wall Street analysts on ACHV. The average recommendation is ‘Strong Buy’. This consensus is based on opinions from 7 analyst(s). Targets average $16.71 (within a range of $10.00 – $30.00). The average target ($16.71) suggests roughly 366.8% potential upside compared to the current price ($3.58). This reflects overall analyst sentiment on the stock’s outlook.
Technical Analysis Summary
This technical overview for ACHV (as of 2025-05-30 00:00:00) covers essential trend, momentum, and volatility indicators. Charts offer more detail, but this summarizes the key signals.
- Trend: Bullish Trend Confirmation, as price ($3.58) holds above both the key 50-day and 200-day SMAs, indicating positive momentum across timeframes.
- Momentum (RSI): ⚠️ 70.8 (Extended), suggesting the rally might be overextended.
Moving Average Details
Remember, technical analysis looks at past data to find potential patterns; it doesn’t predict the future with certainty. Always use it alongside fundamentals and risk control.
Short Selling Info
Short selling data provides a measure of negative sentiment or bets against ACHV. Key short interest indicators include Short % of Float (9.75%) and the Short Ratio (14.80x). The current level is considered moderate. This implies moderate bearish sentiment and suggests moderate short squeeze potential. The high Days to Cover (14.80x) implies it would take significant time for shorts to cover, amplifying potential short squeeze intensity.
| Shares Short | $3 M |
| Short Ratio (Days To Cover) | 14.80x |
| Short % of Float | 9.75% |
| Shares Short (Prior Month) | $3 M |
| Short Date | 2025-05-15 |
Stock Price Statistics
Here we detail ACHV’s price behavior: market sensitivity, historical range, recent volatility, and volume. Key price behavior metrics include Beta (1.64x), the 52-week trading range ($1.84 – $5.49), recent short-term volatility (75.7%), and average trading liquidity (3m Avg Vol: N/A). Beta (1.64x) suggests the stock is more volatile than the overall market. The recent volatility (75.7%) is high, indicating significant price swings.
| 52 Week High | $5.49 |
| 52 Week Low | $1.84 |
| 50 Day MA | $2.66 |
| 200 Day MA | $3.67 |
| Beta | 1.64x |
| Volatility (30d Ann.) | 75.7% 📉 |
Conclusion Outlook
Short-Term Technical Snapshot
- ▲Overall Technical Sentiment: Bullish
- ▲Price Trend vs MAs: bullish (above SMA50/200)
- ⚠️Momentum (RSI): Overbought (70.8)
- 📊Support / Resistance (30d): ~$2.34 / ~$3.64
Longer-Term Fundamental & Forecast Outlook
- ●1-Year Avg. Forecast: ~+0.0% avg. change to ≈$0.00
- ●Fundamental Health: Assessment Incomplete (ROE: -154.55%, D/E: 96.90x)
- ●Valuation Snapshot: Appears Moderate (Fwd P/E: -3.44x)
- ●Recent Growth (YoY): N/A (Rev: N/A, Earn: N/A)
- ▲Analyst Consensus: Strong Buy (Target: $16.71)
Overall Assessment & Outlook
Overall, ACHV combines a technical picture leaning Bullish with a fundamental health assessment of moderate. Valuation appears Appears Moderate (Fwd P/E: -3.44x). Models project a 1-year path indicating relatively flat, targeting ≈$0.00. Investors should weigh these factors against the potential risks outlined earlier and their strategic goals.
Reminder: The following assessment is based on model data and public information, intended for informational use. It is not investment advice. Market conditions change rapidly. Always conduct thorough independent research and consult a qualified financial advisor before making investment decisions.
Risk Factors
Potential investors in ACHV should be aware of several risk factors. The following list highlights key considerations based on data and market dynamics, but may not include all possible risks.
- ⚠️ High Volatility: Recent annualized volatility (75.7%) suggests significant price swings.
- ⚠️ Overall market fluctuations can impact the stock.
- ⚠️ Factors specific to the Biotechnology industry or Healthcare sector can affect performance.
- ⚠️ Changes in macroeconomic conditions (interest rates, inflation) pose risks.
- ⚠️ Unforeseen company events or news can impact the price.